A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on <i>ex vivo</i> platelet reactivityJoseph A. Jakubowski, Christopher D. Payne, Jo Howard et al.|British Journal of Clinical Pharmacology|2012Cited by 24
A Phase 1 Study of Prasugrel in Subjects with Sickle Cell Disease: Effects on In Vivo Markers of Platelet Activation and of CoagulationJoseph A. Jakubowski, Christopher D. Payne, Chunmei Zhou et al.|Blood|2011Cited by 2
A Phase 1 Study of Prasugrel in Subjects with Sickle Cell Disease: Impact on Ex Vivo Platelet ReactivityJoseph A. Jakubowski, Christopher D. Payne, Stipo Jurčević et al.|Blood|2011Cited by 0